Press release - February 3rd, 2015

transcutaneous Vagus Nerve Stimulation with NEMOS now also available for epilepsy patients in the UK

ERLANGEN/ STAFFORDSHIRE, February 2015 – Roughly 0.7 to 1 % of the population suffers from epilepsy. This means there are up to 640,000 sufferers in the UK. Many of these cannot be helped adequately using conventional therapies.
The Erlangen-based medical technology company cerbomed has just announced the immediate availability of transcutaneous vagus nerve stimulation (t-VNS), using the NEMOS therapy device, for epilepsy patients in the UK. This has been made possible by cerbomed‘s new distributor, Delta Surgical Ltd, based in Staffordshire.
The privately run company, founded in 2001, has an experienced field sales and service team. With the addition to its portfolio of the NEMOS therapy device, for treating epilepsy, Delta Surgical extends its offering in neurology.
"We know the high level of suffering of epilepsy patients who cannot achieve satisfactory relief using drug therapies. So we are delighted to be able to make the transcutaneous vagus nerve stimulator NEMOS available in the UK, to provide a further, and very promising treatment alternative," said Robin Humble, Managing Director of Delta Surgical.
"In Delta Surgical we have a valuable and experienced partner on our side for the UK, who are as dedicated to the good of the patients as we are," said Dr. Andreas Hartlep, Chief Executive Officer of cerbomed.

About t-VNS with NEMOS
Transcutaneous Vagus Nerve Stimulation is addressed to patients suffering from various difficult-to-treat neurological and psychiatric diseases. The t-VNS therapy uses the fact that a branch of the vagus nerve is located directly under the skin in areas of the outer ear and therefore can be stimulated through the skin (transcutaneously) with electrical impulses.
With NEMOS cerbomed developed and patented a special stimulator and a dedicated ear electrode for treatment of epilepsies with t-VNS.  The stimulator, which is connected with the ear electrode, sends out the electrical impulses. With the transcutaneous vagus nerve stimulator NEMOS a targeted stimulation of the vagus nerve is possible without the need of a surgery.

About Delta Surgical
Delta Surgical Ltd is a fast growing UK based company that specialise in innovative Medical Device Technology. They work closely with clinicians to develop cost-effective solutions which enhance hospital efficiency, patient care and improve clinical outcomes.
Delta Surgical are the UK distributors for a number of leading medical device manufacturers, with a special interest in Neuro, ENT and Critical Care devices.

For more information please visit www.deltasurgical.co.uk.

About cerbomed
Cerbomed GmbH is an innovative medical device company located in Erlangen, Germany, that focuses on neuromodulation. The company, founded in 2005, focuses on transcutaneous Vagus Nerve Stimulation (t-VNS), which may offer an attractive therapy option for patients with hard-to-treat neurological and psychiatric illnesses.
The t-VNS received the European clearance (CE mark) for the treatment of epilepsies, depression and pain. In 2014 two clinical studies have been completed regarding the effectiveness of t-VNS in patients with drug-resistant epilepsy and chronic migraine.
The therapy device NEMOS is available for treating epilepsies in Germany, Austria, Switzerland, Italy and UK.

pdf Download Article


Please note: NEMOS® is not cleared or approved for use in the U.S.